Overall, these results show that homeostatic levels of CXCR4 protein require CXCR7 expression, and that CXCR4 expression is required for CXCL12-mediated motility in LNCaP prostate-cancer cells. The gene discussed is CXCR4; the disease is prostate carcinoma.